Summit Therapeutics

Summit Therapeutics EPS

The Earnings per Share (EPS) of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -0.31 USD. In the previous year, Earnings per Share (EPS) was -0.99 USD — a change of -68.96% (higher).

EPS

-0.31USD

YoY

-68.96%

Last updated:

Earnings per Share (EPS) of Summit Therapeutics is 2024 -0.31 USD. Earnings per Share (EPS) of Summit Therapeutics was 2023 -0.99 USD. It decreases by -68.96% higher compared to the previous year.

The Summit Therapeutics EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2024
-0.31 USD
Jan 1, 2025 (e)
-1.11 USD
Jan 1, 2026 (e)
-1.07 USD
Jan 1, 2027 (e)
-1.01 USD
Jan 1, 2028 (e)
-0.64 USD
Jan 1, 2029 (e)
0.14 USD
Jan 1, 2030 (e)
1.55 USD
Jan 1, 2031 (e)
3.36 USD
The Summit Therapeutics EPS history
YEAREPSYoY
est3.36USD+116.37%
est1.55USD+974.67%
est0.14USD-122.41%
est-0.64USD-35.98%
est-1.01USD-6.00%
est-1.07USD-3.78%
est-1.11USD+261.60%
-0.31USD-68.96%
-0.99USD+143.55%
-0.41USD-57.58%
-0.96USD+26.71%
-0.76USD-14.57%
-0.89USD-254.43%
0.57USD-128.54%
-2.01USD+479.78%
-0.35USD+1.88%
-0.34USD+18.79%
-0.29USD-3.39%
-0.30USD+10.98%
-0.27USD-11.58%
-0.30USD-46.39%
-0.56USD-65.12%
-1.62USD-80.72%
-8.39USD+113.88%
-3.92USD+154.57%
-1.54USD+145.66%
-0.63USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Earnings per Share (EPS) of Summit Therapeutics is -0.31 USD in 2024.

Earnings per Share (EPS) of Summit Therapeutics changed from -0.99 USD to -0.31 USD, representing a -68.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Summit Therapeutics

All Key Metrics — Summit Therapeutics